Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
St. George, UT
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
St. George, UT
Click here to add this to my saved trials
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Roanoke, VA
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Tacoma, WA
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Status: Enrolling
Updated:  2/16/2016
mi
from
Vancovuer,
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Status: Enrolling
Updated: 2/16/2016
mi
from
Vancovuer,
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Mesa, AZ
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Carlsbad, CA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Castro Valley, CA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Fair Oaks, CA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Fair Oaks, CA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Fresno, CA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Sylmar, CA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Sylmar, CA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Doral, FL
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Doral, FL
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Warner Robins, GA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Warner Robins, GA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Shreveport, LA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Baltimore, MD
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Kansas City, MO
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
New York, NY
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Greenville, NC
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Reading, PA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Reading, PA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
York, PA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
York, PA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
McAllen, TX
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Temple, TX
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Saint George, UT
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Saint George, UT
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Roanoke, VA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated:  2/16/2016
mi
from
Calgary,
Santyl Applications to Diabetic Foot Ulcers
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Status: Enrolling
Updated: 2/16/2016
mi
from
Calgary,
Click here to add this to my saved trials
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  2/16/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 2/16/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Dothan, AL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Huntsville, AL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Tucson, AZ
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Tucson, AZ
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Harrisburg, AR
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Harrisburg, AR
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Little Rock, AR
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Little Rock, AR
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
El Cajon, CA
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
El Cajon, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Lomita, CA
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Los Angeles, CA
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Rialto, CA
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Rialto, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Santa Ana, CA
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Ventura, CA
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Ventura, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Danbury, CT
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
DeLand, FL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Hialeah, FL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Inverness, FL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Inverness, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials